Featured News
Featured Story
Design-Zyme, KU collaboration results in $3 million SBIR award for Lyme disease vaccine development
The woods can be a place of adventure and beauty, a peaceful escape for a walk. But among the leaves and grass, the threat of ticks can turn a hike into a health-altering encounter with Lyme disease. A recent $3 million Small Business Innovation Research award will fund the research and development of a vaccine to stop Lyme disease in its tracks.
More News
Thu, 10/17/2024
The woods can be a place of adventure and beauty, a peaceful escape for a walk. But among the leaves and grass, the threat of ticks can turn a hike into a health-altering encounter with Lyme disease. A recent $3 million Small Business Innovation Research award will fund the research and development of a vaccine to stop Lyme disease in its tracks.
Mon, 09/30/2024
Hyunjoon Kim, CBID research project leader and Assistant Professor of Pharmaceutical Chemistry, was awarded $25,000 by University of Kansas Medical Center Research Institute to study "Novel TLR7/8 agonists for bladder cancer immunotherapy".
Mon, 09/30/2024
Shyam Sathyamoorthi, Associate Professor of Medicinal Chemistry and CBID research project leader graduate, won a new award from Kansas State University. This award will provide $76,500 to study "Illuminating Dark Antibiotics: A Novel Synthesis of Streptothricin F and First Total Synthesis of BD-12 and Albothricin".
Mon, 09/16/2024
Former CBID pilot project leader Wolfram Zückert awarded Chancellors Club Teaching Professorship at The University of Kansas Medical Center.
Mon, 09/09/2024
Pankaj Baral, assistant professor of biology, and Prabhu Raj Joshi, doctoral student in microbiology, are studying how nervous and immune system crosstalk, or bilateral signaling, impacts the body's ability to fight pneumonia caused by the Gram-negative bacteria known as carbapenem-resistant Klebsiella pneumoniae, or CRKP.